Journal article
Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting
Maria Trojano, Helmut Butzkueven, Ludwig Kappos, Heinz Wiendl, Tim Spelman, Fabio Pellegrini, Yi Chen, Qunming Dong, Harold Koendgen, Shibeshih Belachew
Multiple Sclerosis and Related Disorders | ELSEVIER SCI LTD | Published : 2018
Grants
Funding Acknowledgements
This study was supported by Biogen.